thiamine has been researched along with Kidney Diseases in 10 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Since thiamine pyrophosphate is a cofactor in the reaction, thiamine deficiency might be expected to result in tissue oxalosis." | 7.65 | Thiamine deficiency and oxalosis. ( Salyer, DC; Salyer, WR, 1974) |
| " Since thiamine pyrophosphate is a cofactor in the reaction, thiamine deficiency might be expected to result in tissue oxalosis." | 3.65 | Thiamine deficiency and oxalosis. ( Salyer, DC; Salyer, WR, 1974) |
| "Here, we describe an infant with severe Leigh syndrome, nephrotic syndrome, and CoQ(10) deficiency in muscle and fibroblasts and compound heterozygous mutations in the PDSS2 gene, which encodes a subunit of decaprenyl diphosphate synthase, the first enzyme of the CoQ(10) biosynthetic pathway." | 1.33 | Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. ( Dimauro, S; Hirano, M; Kanki, T; López, LC; Naini, A; Quinzii, CM; Rodenburg, RJ; Schuelke, M, 2006) |
| "Biotin was the most effective in providing renal protection and sulfathiazole the least effective, based upon BUN, serum creatinine values, and weight changes, though all four of these compounds provided a considerable measure of protection against the typical cisplatin-induced nephrotoxicity." | 1.28 | Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds. ( Basinger, MA; Holscher, MA; Jones, MM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CASTALDI, D | 1 |
| AVANZINI, M | 1 |
| KUNSTMANN, H | 1 |
| KOBAYASHI, K | 1 |
| SASANO, E | 1 |
| SHIBATA, M | 1 |
| FUJII, R | 1 |
| KATO, K | 1 |
| YOSHIMINE, N | 1 |
| OKURA, Y | 1 |
| TOMIDA, Y | 1 |
| IWAZU, A | 1 |
| HUEBER, EF | 1 |
| LUSSANA, S | 1 |
| López, LC | 1 |
| Schuelke, M | 1 |
| Quinzii, CM | 1 |
| Kanki, T | 1 |
| Rodenburg, RJ | 1 |
| Naini, A | 1 |
| Dimauro, S | 1 |
| Hirano, M | 1 |
| Utter, MF | 1 |
| Sheu, KF | 1 |
| Jones, MM | 1 |
| Basinger, MA | 1 |
| Holscher, MA | 1 |
| Weber, W | 1 |
| Nitz, M | 1 |
| Looby, M | 1 |
| Salyer, WR | 1 |
| Salyer, DC | 1 |
10 other studies available for thiamine and Kidney Diseases
| Article | Year |
|---|---|
[Use of triphosphoric esters of aneurin in uremic kidney disease].
Topics: Esters; Humans; Kidney Diseases; Thiamine; Uremia; Urologic Diseases | 1953 |
[Therapeutic experiences with vitamins B1 and E in acute and chronic diseases of kidney parenchyma].
Topics: Chronic Disease; Humans; Kidney; Kidney Diseases; Thiamine; Vitamin E; Vitamins | 1955 |
THE INFLUENCE OF PHOSPHORUS METABOLISM ON THE RENAL FUNCTION.
Topics: Adenosine Triphosphate; Animals; Blood Chemical Analysis; Chromates; Creatine; Creatinine; Ketogluta | 1963 |
[ON THE USE OF THIANEURONE, A NEW ORAL VITAMIN B-1 PREPARATION, FOR THE THERAPY OF NEURITIC PAINS].
Topics: Anemia; Arthritis; Arthritis, Rheumatoid; Back Pain; Beriberi; Cardiovascular Diseases; Diabetes Mel | 1964 |
[CLINICAL OBSERVATIONS ON THE SUBJECT OF VITAMIN THERAPY].
Topics: Alcoholism; Drug Therapy; Humans; Kidney Diseases; Liver Cirrhosis; Neoplasms; Pyridoxine; Thiamine; | 1964 |
Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations.
Topics: Alkyl and Aryl Transferases; Biotin; Carnitine; Case-Control Studies; Cells, Cultured; Coenzymes; Fi | 2006 |
Biochemical mechanisms of biotin and thiamin action and relationships to genetic disease.
Topics: Animals; Apoenzymes; Biotin; Carboxy-Lyases; Carboxylic Ester Hydrolases; Chickens; Fatty Liver; Hum | 1980 |
Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds.
Topics: Animals; Biotin; Blood Urea Nitrogen; Captopril; Cefoxitin; Cephalexin; Cisplatin; Creatinine; Drug | 1992 |
Nonlinear kinetics of the thiamine cation in humans: saturation of nonrenal clearance and tubular reabsorption.
Topics: Adult; Blood Proteins; Cations; Female; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubul | 1990 |
Thiamine deficiency and oxalosis.
Topics: Acute Kidney Injury; Adipates; Adult; Carboxy-Lyases; Diphosphates; Glyoxylates; Humans; Ketoglutari | 1974 |